Blog

UK biotech Silence Therapeutics raises $58 million for its RNA drive

British biotech group Silence Therapeutics has raised 38.9 million pounds ($58.2 million) by selling two tranches of new shares at 240 pence each to develop its genetic medicine platform. The company, whose technology works by interfering with RNA molecules, said its brokers had sold an additional block of shares to institutions, meeting demand after an initial sale announced on April 2 raised 27.3 million pounds. Chief executive Ali Mortazavi said

4 Skin Conditions That Can Signal Other Health Problems

In many cases, skin conditions are linked to processes occurring throughout the body, and this means they can become risk factors that set you up for other types of illness or injury, says Jonathan Silverberg, MD, assistant professor of dermatology at Northwestern University. Dr. Silverberg was co-author of a JAMADermatology study published earlier this year that found that people with eczema who’d experienced a flare-up in the last year were

U.S. office space rent rises at fastest clip in a decade: report

Stepped-up business hiring pushed the rental price of U.S. office space up 3.1 percent in the first quarter, the highest quarterly gain in a decade, as demand for commercial real estate accelerated, according to Jones Lang LaSalle Inc . Though occupancy growth in office space slowed to just over 6 million square feet from about double that pace throughout 2014, development activity and rental growth in particular sped up, JLL